About the Biodesign Institute
The Biodesign Institute is a place unlike any other. Here, hundreds of scientists — biologists, physicists, chemists, engineers, mathematicians — cross boundaries and work together, creating nature-inspired solutions to global challenges in health, sustainability and security.
Biodesign is hardwired for transdisciplinary research. You won’t find departments here. Instead, we are organized into research centers, which solve problems holistically with teams of faculty from departments across ASU.
A legacy of impact
Biodesign’s research leads to discoveries and inventions that answer today’s challenges.
Our scientists have created a therapy against the Ebola virus, discovered an early diagnostic for breast cancer, provided data that brought potentially harmful chemicals in personal-care products to light, and developed the first publicly available saliva-based COVID-19 test in the nation.
Estimated to support over 3,000 jobs through 2023
Generated more than 969 inventions
Launched 44 spinout companies as of July 2022
A community of experts
Our scientists work in a unique environment that fosters collaboration across disciplines. This research community lays the foundation for connections that lead to rapid answers for some of the world’s most urgent problems.
Connection leads to faster innovation
To succeed in the global economy, Arizona recognized that it must better educate its workforce, attract more investment, expand industrial growth and further new knowledge in critical areas.
The Technology and Research Initiative Fund (TRIF) is a small portion of a sales tax approved by Arizona voters in 2000 to benefit the state’s education system. TRIF empowers research, innovation and workforce development at Arizona’s three public universities.
ASU decided to invest the bulk of its TRIF allocation in bioscience and related technology areas in creating the Biodesign Institute. In 2002, ASU committed to establish the institute as a flagship initiative to advance its scientific research and development capabilities. This investment enabled Biodesign’s first recruitment effort, and we opened our first building — Biodesign A — in 2004.
This goal pushed Biodesign to predict the trajectory of bioscience advances and create large, interdisciplinary programs. This strategy has helped grow a globally competitive biosciences industry cluster in Arizona.
According to the Flinn Foundation’s Bioscience Roadmap report, from 2002 to 2020, Arizona’s non-hospital bioscience industry jobs grew by 113.4%, nearly three times greater than the growth nationwide.
Learn about Biodesign’s award-winning complex and shared instrument facilities that promote collaboration and advance our research.
See where the science happens and learn more about our research centers, each dedicated to a critical topic or foundational area of study.